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ABSTRACT
Background: Rectal cancer staging using rigid probes or echoendoscopes has some
limitations. The aim of the study was to compare rectal cancer preoperative staging using
conventional endoluminal ultrasonography with three-dimensional endoscopic
ultrasonography and miniprobes.
Materials and methods: Sixty patients were included and evaluated with: a) a conventional
echoendoscope (7.5 and 12 MHz); b) miniprobes (12 MHz); and c) the Easy 3D Freescan
software for three-dimensional endoscopic ultrasonography. The reference or gold standard
was conventional endoluminal ultrasonography in all cases and pathological assessment for
those without preoperative therapy. The differences in T and N staging accuracy in both
longitudinal and circumferential extension were evaluated.
Results: With regard to T staging, conventional endoluminal ultrasonography had an
accuracy of 85% (compared to pathological analysis), and the agreement between
miniprobes vs conventional endoluminal ultrasonography (kappa = 0.81) and three-
dimensional endoscopic ultrasonography vs conventional endoluminal ultrasonography (k =
0.87) was significant. In addition, miniprobes had an accuracy of 82% and three-dimensional
endoscopic ultrasonography had a higher accuracy (96%). With regard to N staging,
conventional endoluminal ultrasonography had an accuracy of 91% with a sensitivity of 78%.
However, the agreement between miniprobes and conventional endoluminal
ultrasonography and three-dimensional endoscopic ultrasonography and conventional
endoluminal ultrasonography (k = 0.70) was lower. Interestingly, miniprobes had a lower
accuracy of 81% whereas three-dimensional endoscopic ultrasonography had an accuracy of
100% without any false negative. No false positives were observed in any of the techniques.
Accuracy for T and N staging was not influenced by longitudinal or circumferential
extensions of the tumor in all types of endoscopic ultrasonography analyzed.
Conclusions: Miniprobes and especially three-dimensional endoscopic ultrasonography may
be relevant during rectal cancer staging.
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INTRODUCTION
Magnetic resonance imaging, endoluminal ultrasound and computed tomography are
imaging tools commonly used to evaluate rectal tumor staging (1). Rectal endoluminal
ultrasonography (US) with rigid probes or endoscopic ultrasonography (EUS) is the
preferential method for local staging of rectal carcinoma (RC) and decisively influences the
therapeutic approach of patients (2). Nevertheless, its accuracy varies significantly, ranging
from 63% to 95% for T staging and from 64% to 80% for N staging (1,3-5). It is well known
that operator expertise is an important factor in the accuracy of RC by endoluminal US (6).
However, tumor anatomical characteristics (e.g., stenosis), lymph node location (e.g., pelvic
lateral nodes) or criteria (e.g., size) may also influence the final result (4,7).
Conventional EUS (C-EUS) does not provide whole tumor assessment for all stenosing
tumors. Miniprobe EUS (mp-EUS) may easily overcome these obstacles due to its reduced
diameter and flexibility (8,9). mp-EUS may be the most adequate ultrasonographic tool for
the differential diagnosis of tumors limited to the mucosa (T1m) or with involvement of the
submucosa (T1sm) as it uses high frequencies and thus resolves the limitations of C-EUS
(10,11).
C-EUS provides only two-dimensional images of the lesions and structures. Three-
dimensional EUS (3D-EUS) may be able to provide simultaneous spatial information of
different planes and even a multi-plane vision. It also allows the isolation of structures or
lesions of interest and presents them in different perspectives, changing their texture
and/or transparency (12-15). However, the application of 3D-EUS in this setting has rarely
been reported (12,14,16,17). Therefore, we aimed to compare RC preoperative staging
using C-EUS with 3D-EUS and mp-EUS.
METHODS
Selection of participants
The prospective study was approved by the Ethics Committee for Health of our hospital.
Patients with RC (defined as located up to 15 cm from the anal verge) that underwent
endoscopic ultrasonography staging of the disease gave their written informed consent
prior to inclusion in the study. Patients less than 18 years of age, pregnant women or
individuals unable to give informed consent were excluded.
Procedures
Two enemas were given one hour before the procedures. Three types of equipment were
used in staging: a) a conventional echoendoscope with frequencies of 7.5 and 12 MHz
(Olympus GF-UM20®); b) mp-EUS with 12 MHz (Olympus UM-2R®); and c) 3D-EUS with the
Easy 3D Freescan software from Echotech®. The assessment for T and N stages (defined in
accordance with TNM staging [18]) was initiated with mp-EUS followed by C-EUS. 3D-EUS
was the final technique performed and images were acquired via a conventional
echoendoscope. The identification of lymph nodes in the perirectal space was conducted
from the distal rectum to the iliac vessels. The differences in the ability of the three
techniques to assess the entire lesion were also assessed.
Reference tests
Patients were divided in two groups according to the use of neoadjuvant therapy with
radio/chemotherapy. Prior assessment with a conventional echoendoscopy was performed
before neoadjuvant therapy and was considered as a reference in all cases. Pathological
assessment after surgery was considered as the gold standard for those who did not receive
preoperative therapy.
Statistical analysis
The PASW version 21 software was used for the analysis. The kappa coefficient was used
to estimate the agreement between techniques and accuracy; this was calculated as the
proportion of true results versus the total number of patients. In addition, sensitivity and
specificity were estimated as the proportion of true positive or negative cases, respectively.
The relationship between longitudinal or circumferential extent of the tumor and staging
accuracy was evaluated for all three techniques using a Spearman’s correlation.
RESULTS
Sixty patients aged between 34 and 89 years (mean value of 63.8  11.8) were assessed, and
36 (60%) patients were male. All patients underwent surgery, 27 (45%) without
preoperative adjuvant therapy.
Mp-EUS assessed the lesion in its entirety in 97% of cases, whereas this was achieved less
frequently via C-EUS and 3D-EUS, in 85% of cases (p = 0.01). Staging was not possible using
C-EUS in 15% (n = 9) of cases vs 3% (n = 2) of cases with mp-EUS, due to tumor stenosis. In
these cases where it was not possible to evaluate the whole of the tumor, T and N stages
results were based on the tumor extent that was observed.
T Staging
Comparison of T staging by mp-EUS, 3D-EUS and C-EUS in all patients (n = 60) (Table 1)
Both the mp-EUS and 3D-EUS techniques were highly concordant with C-EUS for T staging,
with Kappa coefficients of 0.81 and 0.87. Global accuracy of T staging by mp-EUS compared
to C-EUS was 86.7% and 81.7% compared to 3D-EUS.
Comparison of T staging obtained using different EUS techniques and
anatomopathological staging (APS) (n = 27) (Table 2)
T staging by C-EUS, mp-EUS and 3D-EUS was concordant with APS with Kappa coefficient
values of 0.81, 0.76 and 0.95, respectively.
Simultaneous comparison of T staging using the three EUS techniques and T APS (n = 27)
(Table 2)
There were no significant differences with regard to the simultaneous comparison of the
three techniques (p = 0.75).
N Staging
Comparison of N staging by mp-EUS, 3D-EUS and C-EUS staging in all patients (n = 60)
(Table 3)
The mp-EUS and 3D-EUS analyses were concordant with C-EUS for N staging, with kappa
coefficients of 0.65 and 0.79, respectively.
The sensitivity of C-EUS compared to mp-EUS and 3D-EUS for the identification of
metastasized nodes was 73.1% and 92.3%, respectively. The corresponding values for
specificity were 91.2% and 79.4%, positive predictive values were 86.4% and 77.4%,
negative predictive values were 81.6% and 93.1% and global accuracy was 83.3% and 85%,
respectively.
Comparison of N staging obtained via different EUS techniques and APS (n = 21) (Table 4)
Anatomopathological information with regard to the presence of metastasized nodes was
available in 21 (77.8%) cases. Of the 27 patients that underwent surgery, it was not possible
to obtain this information in six (22.2%) cases as a transanal resection was performed. N
staging by C-EUS, mp-EUS and 3D-EUS and pathological analysis were concordant with
respective kappa coefficients of 0.80, 0.59 and 1. The sensitivity of C-EUS, mp-EUS and 3D-
EUS for the identification of metastasized nodes was 77.8%, 55.6% and 100%, respectively.
The corresponding values for specificity and positive predictive values were 100% for the
three techniques, whereas the negative predictive values were 85.7%, 75% and 100% and
global accuracy was 90.5%, 81% and 100%, respectively.
Simultaneous comparison of N staging accuracy using the three EUS techniques and N APS
(n = 21) (Table 4)
There were no significant differences between the three techniques (2 = 4.42; p = 0.11).
DISCUSSION
The continuous technological development has led to the application of new techniques
associated with endoscopic ultrasonography (19). Good results were obtained in this study
with mini-probes and three-dimensional endoscopic ultrasonography.
There was a significant agreement with regard to T staging between miniprobes, 3D and
conventional EUS. These values range between 77 and 93% in previous reports
(12,14,16,17). Our findings confirm the high accuracy of 3D-EUS, which is higher than that of
conventional EUS. However, stenosing rectal cancer cannot be assessed either by C-EUS or
3D-EUS in up to 21.6% of cases (20), the rate was 15% in our study. Interestingly, miniprobe-
EUS allowed the identification of most lesions in their entirety. Miniprobes can in fact
transpose stenosing RC (Fig. 1), overcoming the rigid end and “large” diameter
characteristics of C-EUS, which may inhibit RC staging (4,7).
Both 3D-EUS and mp-EUS had a high accuracy (Fig. 2) for T1 staging, which is in agreement
with previous reports (21,22). With regard to T2 staging, 3D was superior to mp-EUS, which
tended to overstage tumors (12,16,17,22-24). A very high accuracy for T3 staging was
reported for 3D or mp-EUS (12,16,17,23-26), whereas mp-EUS had the lowest accuracy in
relation to the higher ultrasound frequency for T4 staging, which is in line with current
evidence (17,24-27). The use of 3D for T staging of rectal cancer had the best accuracy with
mp and allowed the staging of stenosing tumors, although with some limitations for large
masses (e.g., T4 staging).
With regard to lymph node diagnosis with EUS, the results obtained with mp-EUS and 3D-
EUS were also encouraging since they were in significant concordance with C-EUS, with a
global accuracy of 90.5%. The highest sensitivity was obtained with 3D-EUS (100%), as well
as a very high negative predictive value (100%). This not only represents the high capacity of
3D-EUS to identify lymph nodes but also reinforces our option for not imposing a cut-off
value for node diameter in order to classify it as metastasized. However, there is no
consensus with regard to this matter (28,29). In fact, this trend to improved accuracy was
also observed in other studies (12,17,30,31).
In conclusion, Mp-EUS and 3D-EUS are valid techniques compared to C-EUS for RC staging.
We suggest that Mp-EUS may be an alternative to C-EUS due to the possibility of staging a
carcinoma during colonoscopy with interesting T-staging results, and it can usually assess
the entire tumor mass. This is an advantage for stenosing masses. More importantly, even
though the results were not statistically significant in the comparison of 3D-EUS with C-EUS,
this technique may become the gold standard method in RC staging. This will ultimately
improve the clinical decisions taken with regard to these patients, particularly for T2 vs T3
staging, which is highly relevant in patient management.
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Table 1. Accuracy and agreement for T staging using conventional (C-EUS) as a reference
for miniprobes (accuracy = 87%, kappa = 0.81) and 3D-EUS (accuracy = 82%, kappa = 0.87).
Total n = 60
Accuracy (%)
C-EUS (n)
T staging
T1m T1sm T2 T3 T4
Miniprobes (n) 87 (74-100)
T1m 100 (100-100) 8
T1sm 80 (65-95) 4 1
T2 73 (56-90) 2 8 1
T3 96 (89-100) 1 26
T4 67 (49-85) 3 6
3D-EUS (n) 82 (68-97)
T1m 100 (100-100) 5 2
T1sm 60 (42-78) 3
T2 73 (56-90) 8
T3 89 (77-100) 3 24
T4 100 (100-100) 3 9
Table 2. Accuracy and agreement for T staging using pathology as a reference for
conventional EUS (C-EUS) (accuracy = 85%, kappa = 0.81), miniprobes (accuracy = 82%,
kappa = 0.76) and 3D-EUS (accuracy = 96%, kappa = 0.95). Total n = 27
Accuracy (%)
Pathology
T staging
T1m T1sm T2 T3 T4
C-EUS (n) 85 (72-98)
T1m 80 (65-95) 8
T1sm 75 (59-91) 2 3
T2 100 (100-100) 1 4
T3 100 (100-100) 5 1
T4 75 (59-91) 3
Miniprobes (n) 82 (68-96)
T1m 90 (79-100) 9 1
T1sm 75 (59-91) 1 3
T2 75 (59-91) 3
T3 100 (100-100) 1 5 2
T4 50 (31-69) 2
3D-EUS (n) 96 (89-100)
T1m 90 (79-100) 9
T1sm 100 (100-100) 1 4
T2 100 (100-100) 4
T3 100 (100-100) 5
T4 100 (100-100) 4
Table 3. Accuracy and agreement for N staging using conventional EUS (C-EUS) as a
reference for miniprobes (accuracy = 83%, kappa = 0.65) and 3D-EUS (accuracy = 85%,
kappa = 0.70). Total n = 60
Accuracy (%)
C-EUS (n)
N staging
N0 N+
Miniprobes (n) 83 (69-97)
N0 91 (80-100) 31 7
N+ 73 (56-90) 3 19
3D-EUS (n) 85 (72-98)
N0 79 (64-94) 27 2
N+ 92 (82-100) 7 24
Table 4. Accuracy and agreement for N staging using pathology as a reference for
conventional EUS (C-EUS) (accuracy = 90%, kappa = 0.80), miniprobes (accuracy = 81%,
kappa = 0.59) and 3D-EUS (accuracy = 100%, kappa=1). Total n = 21
Accuracy (%)
Pathology
N staging
N0 N+
C-EUS (n) 90 (77-100)
N0 86 (71-100) 12
N+ 100 (100-100) 2 7
Miniprobes (n) 81 (64-98)
N0 100 (100-100) 12 4
N+ 56 (38-77) 5
3D-EUS (n) 100 (100-100)
N0 100 (100-100) 12
N+ 100 (100-100) 9
Fig. 1. Stenosing RC. A. Observation by colonoscopy with a miniprobe inserted in the lumen.
B. Ultrasonographic image showing the invasion by perirectal fat.
Fig. 2. RC staging by 3D-EUS with invasion of the submucosa but without surpassing it, as
confirmed by the surgical sample.
